These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 10310561)
1. Part one: How do hospital directors plan to cope with the constraints of DRGs? Lantos RL Pharm Times; 1984 Apr; 50(4):66, 68-9. PubMed ID: 10310561 [No Abstract] [Full Text] [Related]
2. DRGs and variance analysis: Part I. Wilson CN Hosp Pharm; 1984 Aug; 19(8):566-8. PubMed ID: 10310771 [No Abstract] [Full Text] [Related]
3. DRGs and variance analysis: Part II. Wilson CN Hosp Pharm; 1984 Sep; 19(9):631-2. PubMed ID: 10310772 [No Abstract] [Full Text] [Related]
4. DRGs: what's in for pharmacy. Sok JE Curr Concepts Hosp Pharm Manage; 1984; 6(3):9-13. PubMed ID: 10310683 [No Abstract] [Full Text] [Related]
5. ABC analysis of the relationship between pharmacy charges and DRGs. Magee MJ; Pathak DS; Sherrin TP; Schneider DN Am J Hosp Pharm; 1985 Mar; 42(3):571-6. PubMed ID: 3920903 [TBL] [Abstract][Full Text] [Related]
6. The effects of DRGs and cost-containment: assessment by hospital pharmacy directors. McGhan WF; Larson LN; Raisch DW Hosp Formul; 1986 Aug; 21(8):870-1, 874-6. PubMed ID: 10311626 [TBL] [Abstract][Full Text] [Related]
8. Pharmacy status v standards: an updated survey. Jeffrey LP; Gallina JN Curr Concepts Hosp Pharm Manage; 1984; 6(1):9-11. PubMed ID: 10310369 [No Abstract] [Full Text] [Related]
9. Preparing for prospective pricing. Zellmer WA Am J Hosp Pharm; 1983 Sep; 40(9):1479. PubMed ID: 6414291 [No Abstract] [Full Text] [Related]
10. Financial tools in evaluating profit and DRG cost determination. Wilson CN Hosp Pharm; 1984 Jun; 19(6):438-9. PubMed ID: 10310618 [No Abstract] [Full Text] [Related]
11. Pharmacists eye share of patient care pie. Carrell S Am Med News; 1983 May; 26(17):3, 24-5. PubMed ID: 10325071 [No Abstract] [Full Text] [Related]
12. DRGs: implications for hospital pharmacy practice. Enright SM Top Hosp Pharm Manage; 1984 Feb; 3(4):10-8. PubMed ID: 10314053 [No Abstract] [Full Text] [Related]
13. Identification of drug costs within diagnosis related groups. Kolar R; Stanaszek W; Osborne J; Dougherty K Hosp Pharm; 1984 Nov; 19(11):731-5. PubMed ID: 10310864 [TBL] [Abstract][Full Text] [Related]
15. Identifying disease-drug cost indicators using diagnosis-related groups. Prince AK Am J Hosp Pharm; 1986 Jun; 43(6):1503-4. PubMed ID: 3088994 [No Abstract] [Full Text] [Related]
16. Creating standard treatment protocols: an analysis of pharmacy charges as an aid in their development. Boothe CD; Ferencz N Hosp Formul; 1987 Oct; 22(10):873-5, 879-81. PubMed ID: 10312221 [TBL] [Abstract][Full Text] [Related]
17. Alternative systems--Massachusetts and New Jersey. Hassan WE; Davis DW Curr Concepts Hosp Pharm Manage; 1984; 6(3):7-8. PubMed ID: 10310682 [No Abstract] [Full Text] [Related]